false
Catalog
2023 World Conference on Lung Cancer (Posters)
EP17.02. Concordance on Treatment Recommendations ...
EP17.02. Concordance on Treatment Recommendations from Multidisciplinary Tumor Boards -Data from Driver-Mutated Lung Cancer in Focus - PDF(Slides)
Back to course
Pdf Summary
A study conducted at a certified lung cancer center in Northern Germany investigated the concordance on treatment recommendations from multidisciplinary tumor boards (MTB) for lung cancer patients with driver mutations. Multidisciplinary tumor boards aim to develop the best treatment plan based on national medical society guidelines while considering the individual patient's case. The study included 644 patients, out of which 12% had driver mutations. The overall concordance rate of treatment recommendations from the tumor boards was 85%, with partial concordance at 9% and discordance at 6%. Among patients with driver mutations, the concordance rate was higher at 91%. Patients who had complete concordance with the tumor board recommendations had an overall survival of 17 months, compared to 4 months for patients with discordant treatment. Additionally, the study found that driver-mutated patients who received concordant treatment had a longer overall survival of 21 months, compared to 2 months for those with discordant treatment. The results suggest that patients with concordant treatment had significantly longer overall survival than those with discordant treatment. The study concludes that assessing concordance to MTB recommendations could become a quality criterion for cancer centers in Germany.
Asset Subtitle
Julia Roeper
Meta Tag
Speaker
Julia Roeper
Topic
Global Health, Health Services & Health Economics: Health Care Utilization
Keywords
lung cancer
certified lung cancer center
Northern Germany
treatment recommendations
multidisciplinary tumor boards
driver mutations
concordance rate
overall survival
medical society guidelines
quality criterion
×
Please select your language
1
English